A $77m deal with creditors to purchase GenCanna as a going concern looks unlikely to be the final step in an ongoing bankruptcy drama surrounding one of the US’s largest hemp processing companies
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.